share_log
Reuters ·  Oct 31, 2024 10:31
Matinas BioPharma - Intends to Retain Advisor to Assist Company With Potential Asset Sale of Mat2203
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 241

Recommended

Write a comment